Agilent Analytical Studio Reviewer Maximizes Efficiency in Early Drug Discovery

Update: 28 September, 2023

This document describes how a pharmaceutical company maximizes efficiency in early drug discovery by using Agilent Analytical Studio Reviewer (ASR) for high-throughput LC/MS analyses to determine the correct compounds. The company is one of the largest pharmaceutical companies in Japan, with a focus on developing drugs in the therapeutic categories of urology, immunology and infectious diseases, oncology, neuroscience, diabetes mellitus complications, and metabolic diseases.

---

File format: PDF

Size: -

MD5 Checksum: 2A38D7987E44DD9D6C763B553EB52B51

Publication date: 11 June, 2012

Downloads: -

PDF Link: Agilent Analytical Studio Reviewer Maximizes Efficiency in Early Drug Discovery PDF